Skip to content

Prevent postoperative agitation and pain in children

does intraoperative clonidine reduce postoperative agitation in children anaesthetized with sevofluran? A RCT including pharmacokinetic investigation - PREVENT AGITATION

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2014-001466-10-DK
Enrollment
Unknown
Registered
2014-07-24
Start date
2014-10-10
Completion date
Unknown
Last updated
2015-12-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative agitation MedDRA version: 18.0 Level: LLT Classification code 10056436 Term: Psychomotor agitation System Organ Class: 100000004852

Interventions

Trade Name: Catapresan solution for injection 150 micg/ml Product Name: Catapresan Pharmaceutical Form: Solution for injection INN or Proposed INN: clonidine hydrochloride Other descriptive name: CLON

Sponsors

Copenhagen University Hospital, Rigshospitalet, Juliane Marie Centre, Department of Anaesthesiology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: children between 1 and 6 years of age scheduled for Anastasia with Sevofluran Are the trial subjects under 18? yes Number of subjects for this age range: 2 F.1.2 Adults (18-64 years) no F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: ASA >2 Premedication with Clonidin. Ex-premature (born before week 37+0 AND 50 kg Allergy to Clonidin. Patients treated with methylphenidate / Concerta.

Design outcomes

Primary

MeasureTime frame
Main Objective: Does Clonidine reduce postoperative agitation in children;Secondary Objective: not applicable;Primary end point(s): Postoperative agitation;Timepoint(s) of evaluation of this end point: Measured on the Watcha Scale

Secondary

MeasureTime frame
Secondary end point(s): Pain reduction. Serious side effects during admission and up to 30 days after the operation. ;Timepoint(s) of evaluation of this end point: During recovery, admission and up to 30 days after the operation.

Countries

Denmark

Contacts

Public ContactMogens Ydemann

Copenhagen University Hospital, Rigshospitalet, Juliane Marie Centre, Department of Anaesthesiology

mogens@ydemann.dk

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026